NEOG Neogen Corporation

Shares of life sciences company Neogen (NASDAQ:NEOG) fell 5.4% in the afternoon session after the U.S. Food and Drug Administration issued warning letters to the company following laboratory tests that uncovered fungal contamination in its veterinary product HYCOAT.

“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.

Neogen has delivered a sharp share price swing in a short span, and the recent run has investors asking whether the current valuation is still grounded in its sales profile. With the stock now reflecting a very different market view than a few years ago, the key issue is how that view lines up with what the business actually generates in revenue. The stock has returned 153.2% over the past year, which puts real pressure on the question of whether today’s price can be explained by its sales...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 38.9% gain over the past six months, beating the S&P 500 by 20.9 percentage points.

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

Kestra Medical Technologies, Ltd. (KMTS) delivered earnings and revenue surprises of -22.95% and +6.66%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?

PBH vs. NEOG: Which Stock Is the Better Value Option?

Over the past six months, Neogen has been a great trade, beating the S&P 500 by 8.3%. Its stock price has climbed to $11.93, representing a healthy 21% increase. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.

NEOG advances product innovation and recovers Animal Safety operations, but high debt and intense competition remain key risks.

The Cooper Companies (COO) delivered earnings and revenue surprises of +3.60% and -2.97%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?

Recent commentary around Neogen (NEOG) has focused on two pressure points for investors. Annual sales have declined for two years and returns on capital have shrunk, while a higher net debt to EBITDA ratio raises balance sheet sensitivity. The recent share price reflects that mixed picture. Neogen’s stock is up 29.5% on a 90 day share price return and 68.71% year to date, while the 1 year total shareholder return of 106.47% contrasts with a 3 year total shareholder return that has fallen...

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.

Neogen stock has more than doubled over the past year, yet the broader valuation checks lean expensive rather than cheap, which may give investors pause after such a strong run. The share price has returned 106.5% over the past year, which sets a high bar for any further gains to be justified by fundamentals. Future growth in Neogen's revenue and cash generation can support the current share price, but any disappointment in execution or profitability may weigh heavily given the recent...

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.

NEOG shares gain 102.8% in a year as R&D investments, Food Safety growth and improving Animal Safety conditions fuel momentum despite key risks.

PRGO vs. NEOG: Which Stock Is the Better Value Option?

Intuit downgraded, SolarEdge upgraded: Wall Street's top analyst calls

Does Neogen (NEOG) have what it takes to be a top stock pick for momentum investors? Let's find out.

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.

Neogen (NEOG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

PRGO vs. NEOG: Which Stock Is the Better Value Option?

Food Safety segment drives 4.3% core growth as company executes transformation strategy.

How Neogen’s latest earnings report is shaping the stock story Neogen (NEOG) has just reported fourth quarter and full year results to May 31, 2026, alongside fresh revenue guidance for fiscal 2027. This combination of backward looking figures and management expectations is now in focus for investors. For the fourth quarter, Neogen reported revenue of US$225.3 million compared with US$225.5 million a year earlier. The company recorded a net loss of US$11.3 million, while the prior year...

Neogen Corporation recently reported fiscal fourth-quarter and full-year 2026 results, posting Q4 revenue of US$225.3 million with a US$11.3 million net loss, and issued fiscal 2027 revenue guidance of US$880 million to US$885 million alongside plans for increased R&D and transformation spending. Despite full-year revenue easing to US$870.4 million and a US$7.9 million annual net loss, Neogen sharply reduced losses from the prior year while boosting core revenue growth and outlining plans to...

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.

Neogen Corp (NEOG) reports a 7% year-over-year revenue increase in Q4, driven by food safety and animal health demand, while navigating foreign exchange pressures and supply chain disruptions.

The headline numbers for Neogen (NEOG) give insight into how the company performed in the quarter ended May 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Life sciences company Neogen (NASDAQ:NEOG) reported Q2 CY2026 results topping the market’s revenue expectations, but sales were flat year on year at $225.3 million. The company’s full-year revenue guidance of $882.5 million at the midpoint came in 3.9% above analysts’ estimates. Its non-GAAP profit of $0.09 per share was 58.8% above analysts’ consensus estimates.

Neogen (NASDAQ:NEOG) reported fiscal fourth-quarter revenue of $225.3 million, with core revenue growth of 4.3%, its highest growth rate of fiscal 2026. The company said momentum improved across both its food safety and animal safety businesses as it entered fiscal 2027, while management outlined in

Neogen (NEOG) delivered earnings and revenue surprises of +80.00% and +6.29%, respectively, for the quarter ended May 2026. Do the numbers hold clues to what lies ahead for the stock?

Life sciences company Neogen (NASDAQ:NEOG) will be reporting earnings this Thursday morning. Here’s what to expect.

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.